This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (8)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Amyotrophic Lateral Sclerosis  • Cognitive Disorders  • Dementias  • Neuromuscular diseases  • Neurology, Other  • Alert me on articles by topic  Social Bookmarking   What's this?

Jennifer Murphy, PhD; Roland Henry, PhD; Catherine Lomen-Hoerth, MD, PhD

Arch Neurol. 2007;64(3):330-334.

This review summarizes recent advances in our understanding of the cognitive changes seen in patients with amyotrophic lateral sclerosis (ALS). Emphasis is placed on identifying and diagnosing subtypes of ALS patients with a continuum of frontotemporal impairment. The reviewed literature focuses on progress made in the past 20 years, with an emphasis on studies measuring abnormalities in ALS patients without dementia. We describe peer-reviewed journal articles using neuropsychological batteries and imaging techniques. We also discuss debates raised in recent meetings. In the past 2 decades, the field of ALS has been transformed in terms of its understanding of extramotor cerebral changes. Particularly in the past 10 years, investigators have invalidated the theory that cognitive abnormality in ALS patients is simply a rarely occurring, frank frontotemporal lobar degeneration syndrome. Instead, a growing body of evidence suggests that ALS patients with comorbid frontotemporal lobar degeneration lie on a spectrum of frontotemporal abnormality, with a large proportion of ALS patients possessing a range of behavioral and cognitive changes. As more investigations use standardized tools measuring behavior and cognition, distinct subtypes may be diagnosed.

Author Affiliations: ALS Center (Drs Murphy and Lomen-Hoerth) and Departments of Neurology (Drs Murphy and Lomen-Hoerth) and Radiology (Dr Henry), University of California at San Francisco.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A novel TARDBP mutation in an Australian amyotrophic lateral sclerosis kindred
Williams et al.
J. Neurol. Neurosurg. Psychiatry 2009;80:1286-1288.
ABSTRACT | FULL TEXT  

Inaugural Article: A mouse forward genetics screen identifies LISTERIN as an E3 ubiquitin ligase involved in neurodegeneration
Chu et al.
Proc. Natl. Acad. Sci. USA 2009;106:2097-2103.
ABSTRACT | FULL TEXT  

TDP-43 Proteinopathy in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis: Protein Misfolding Diseases Without Amyloidosis
Neumann et al.
Arch Neurol 2007;64:1388-1394.
ABSTRACT | FULL TEXT